S. 3250
Referred to CommitteeDHS Opioid Detection Resilience Act of 2020
Latest Action
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
2/4/2020 • Senate
Summary
DHS Opioid Detection Resilience Act of 2020
This bill establishes new requirements related to the detection of illicit narcotics at ports of entry.
Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition.
Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.
Introduced in Senate • 2/4/2020
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (5)
Party Breakdown
Sponsor
Cosponsors (4)
Bill Journey
Originated in the Senate
Introduced
February 4, 2020
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law